Generix gives a new impetus to its innovation strategy for customers. Generix accelerates innovation and prepares the company for highly scalable future revenue growth. The investment is intended to completely reinvent the way Generix designs, develops, sells, operates and delivers unique value to customers with a renewed portfolio of digital applications and technologies: AI-ready, fully composable, truly open and cloud-agnostic. The innovations are intended to be delivered incrementally for easy consumption with outcome-based roadmaps, frequent product updates and customer-focused migrations so customers can adopt new solutions at their own pace. You can access the full press release here: https://bit.ly/3VLK6w9
Generix’s Post
More Relevant Posts
-
Building emerging skill sets can help drive innovation and product development for #MedTech companies. But what about “classic” capabilities that sustain existing products? A #DeloitteRippleEffect story explores this delicate balance.
-
Building emerging skill sets can help drive innovation and product development for #MedTech companies. But what about “classic” capabilities that sustain existing products? A #DeloitteRippleEffect story explores this delicate balance.
Can the current big thing get in the next big thing's way?
ambassadorcentral.deloitte.com
-
Building emerging skill sets can help drive innovation and product development for #MedTech companies. But what about “classic” capabilities that sustain existing products? A #DeloitteRippleEffect story explores this delicate balance.
Can the current big thing get in the next big thing's way?
ambassadorcentral.deloitte.com
-
Building emerging skill sets can help drive innovation and product development for #MedTech companies. But what about “classic” capabilities that sustain existing products? A #DeloitteRippleEffect story explores this delicate balance.
Can the current big thing get in the next big thing's way?
ambassadorcentral.deloitte.com
-
Building emerging skill sets can help drive innovation and product development for #MedTech companies. But what about “classic” capabilities that sustain existing products? A #DeloitteRippleEffect story explores this delicate balance.
Can the current big thing get in the next big thing's way?
ambassadorcentral.deloitte.com
-
Building emerging skill sets can help drive innovation and product development for #MedTech companies. But what about “classic” capabilities that sustain existing products? A #DeloitteRippleEffect story explores this delicate balance.
Can the current big thing get in the next big thing's way?
ambassadorcentral.deloitte.com
-
Building emerging skill sets can help drive innovation and product development for #MedTech companies. But what about “classic” capabilities that sustain existing products? A #DeloitteRippleEffect story explores this delicate balance.
Can the current big thing get in the next big thing's way?
ambassadorcentral.deloitte.com
-
Building emerging skill sets can help drive innovation and product development for #MedTech companies. But what about “classic” capabilities that sustain existing products? A #DeloitteRippleEffect story explores this delicate balance.
Can the current big thing get in the next big thing's way?
ambassadorcentral.deloitte.com
-
IT Leader - Global ERP Strategy, Enterprise ERP, AMS, Digital Transformation. Global Delivery. Energy Resources & Industrials - Oil & Gas, Deloitte Consulting, Houston, TX
Building emerging skill sets can help drive innovation and product development for #MedTech companies. But what about “classic” capabilities that sustain existing products? A #DeloitteRippleEffect story explores this delicate balance.
Can the current big thing get in the next big thing's way?
ambassadorcentral.deloitte.com
-
FSI [Investment Management], Team Leader, People First, Father, Coach, Mentor, Auditor - Deloitte US
Building emerging skill sets can help drive innovation and product development for #MedTech companies. But what about “classic” capabilities that sustain existing products? A #DeloitteRippleEffect story explores this delicate balance.
Can the current big thing get in the next big thing's way?
ambassadorcentral.deloitte.com
